the on demand content of the IFCC webinar on “Clinical Applications of Thrombosis and Hemostasis - 血栓与止血的临床应用” held on June 6, 2021 is available at this link.
Thrombosis and hemostasis tests are of importance for the diagnosis of hemorrhagic diseases and disseminated intravascular coagulation (DIC). They are laboratory determinants for the mechanism of thrombosis occurrence, the classification and diagnosis of thrombotic diseases and thrombophilia, as well as the indices of the monitoring of anticoagulant therapy. Several studies showed that thromboembolic events were a serious complication of coronavirus disease 2019 (COVID-19). Autopsy revealed that the death was associated with pulmonary thromboembolism and DIC. In this webinar we provided an overview on the clinical application of thrombosis and hemostasis tests in the monitoring of new oral anticoagulants, in the diagnosis of thrombosis and hemostasis, and the performance of thrombosis and hemostasis tests in COVID-19 patients.
The IFCC Live Webinar Series is partially sponsored by Siemens and Boston Children's Hospital